Breaking News
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
New book explores unlikely origins of food regulation

New book explores unlikely origins of food regulation

image_pdfDownload PDFimage_print

Milk may seem as wholesome a drink as there is, but it was not always so.

Consider the U.S. in the late 19th century. At the time, producers of milk — especially milk sold in U.S. cities — frequently watered it down. The resulting liquid was blended with chalk or plaster of Paris to appear more white. And that wasn’t the half of it: Milk often contained formaldehyde and a cleaning product called Borax. Thousands of people, including children, died from drinking milk.

Eventually, the federal government got around to cleaning up milk production, after landmark legislation in 1906. The safe milk we drink today is a result of that law. But getting to that point required a decades-long struggle by outraged advocates — among them Chicago activist Jane Addams, writer Upton Sinclair, and, not least, a crusading scientist named Harvey Washington Wiley, the chief chemist of the U.S. Department of Agriculture.

Wiley’s odyssey as a reformer and government official is at the center of a new book by MIT’s Deborah Blum, “The Poison Squad,” just published by Penguin Press. In it, Blum details the nascent 19th-century science and politics of food regulation, from the early efforts to figure out what dangers lay in food, to the torturous struggle to push regulations through the political system.

Wiley made headlines at the time through his efforts to reform food production and make eating safer for all Americans. Today, his legacy is little-known, which is a major reason why Blum wanted to reestablish his importance to us.

“I’m really interested in scientists who drive paradigm shifts,” says Blum, the director of the Knight Science Journalism program at MIT and author of several books on science research and the history of science. Wiley, she adds, was a “catalyst” without whom daily life would have been worse for tens of millions of people.

“I don’t mean the whole world was suddenly convulsed,” Blum added. “But he changed the way people think. And that’s a reminder that any of us can change the national or global conversation in a way that does good.”

A “really crazy experiment”

Wiley was an Indiana-bred, Harvard University-educated chemist who became an early faculty member at Purdue University. From there, after making his name through studies of multiple kinds of flawed food, he took his post at the U.S. Department of Agriculture.

As Blum makes clear, there was plenty for food reformers to study. As food production became more industrialized in an urbanizing country, food fakery abounded. “Honey” was often corn syrup, and “vanilla” was often alcohol and food coloring. Coffee could contain sawdust, and brown sugar was notoriously spiked with crushed insects at times.

The book’s title stems from one project Wiley undertook, in which he recruited men in their 20s — “the Poison Squad” — to eat three free meals a day. Some of those people were consuming food with laced with chemicals of uncertain effect, or other dubious ingredients.

“It’s this really crazy experiment you could never do today, in which a government scientist persuades government employees to dine really dangerously,” Blum notes.

Eventually Wiley — and others — amassed plenty of evidence showing that food regulations were necessary. Getting such legislation passed was a saga of its own, and as Blum details in the book, Wiley had a strained relationship with Theodore Roosevelt, the president who ultimately signed the laws Wiley had been fighting for. In theory, these two reformers might have seemed natural allies. In practice, relations between them were fraught.

“Here you have two men who are both progressive and who both want to change the country for better, and who both believe that the current system of poorly regulated industry and business is doing a disservice to the country,” Blum observes. “So you would expect them to be on the same page, but in fact they clashed from the beginning. … I think basically Roosevelt didn’t like him. And that worked against him [Wiley]. He charmed a lot of people, but he never charmed Teddy Roosevelt.”

One reason for this, Blum suggests, is that while Roosevelt was famous for breaking up monopolies, he was in fact fairly comfortable with big business, under the right conditions. But Wiley was, long before it became more fashionable, a relentless consumer advocate, above all. His unyielding consumer focus did not correspond to Roosevelt’s priorities as much as the president’s reputation might suggest.

“I had to fight my way back to liking Teddy Roosevelt after doing the book,” Blum says.

An education in history

For her part, Blum also says she hopes readers come away from “The Poison Squad” thinking that it has “all kinds of lessons for today” about both the discovery of diluted food products and the enforcement issues that arise once laws are passed. A significant part of Blum’s book, for that matter, scrutinizes the enforcement challenges that arose after the food safety legislation was passed.

To be sure, cases of deception in food production are still with us — many kinds of seafood, for example, are not what they appear on the label. Then there are grey areas, where older laws “are completely inadequate for the 21st century,” as Blum puts it, due to changes in the way food is produced.

Many kinds of drinks do not fully list their ingredients, for instance, due to policy compromises between regulators and industry that allow manufacturers to keep ingredients as proprietary information.

“Natural flavorings,” says Blum. “What are they? You’re never going to know.”

Researching and writing the book, Blum says, was thus instructive to her about the progress of science, as well as the tensions and conflicts that have existed among corporations, consumers, and government — and still do.

“It was an education for me,” Blum says. “An education in American history.”

Source:

http://news.mit.edu/2018/food-safety-the-poison-squad-1003

Tagged with:

About author

Related Articles